Management of hepatitis C in patients with chronic kidney disease

Letter: telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis

(2014) J. Wiegand et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial

(2014) Xavier Forns et al.   GASTROENTEROLOGY

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial

(2014) Chen-Hua Liu et al.   GUT

Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin

(2014) Teresa Santantonio et al.   HEPATOLOGY

Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysis

(2014) Clara T.M.M. de Kanter et al.   JOURNAL OF CLINICAL VIROLOGY

Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients

(2014) Seema Baid-Agrawal et al.   JOURNAL OF HEPATOLOGY

Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies

(2014) F. Fabrizi et al.   JOURNAL OF VIRAL HEPATITIS

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

(2014) Ira M Jacobson et al.   LANCET

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

(2014) Michael Manns et al.   LANCET

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

(2014) Eric Lawitz et al.   LANCET

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

(2014) Mark S. Sulkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interferon-Based Anti-Viral Therapy for Hepatitis C Virus Infection after Renal Transplantation: An Updated Meta-Analysis

(2014) Fang Wei et al.   PLoS One

Pegylated Interferon-α2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis

(2013) Chen-Hua Liu et al.   ANNALS OF INTERNAL MEDICINE

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation

(2013) Johanna Knapstein et al.   DIGESTIVE AND LIVER DISEASE

Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C

(2013) Faisal M. Sanai et al.   JOURNAL OF HEPATOLOGY

Meta-analysis of observational studies: hepatitis C and survival after renal transplant

(2013) F. Fabrizi et al.   JOURNAL OF VIRAL HEPATITIS

How to optimize HCV therapy in genotype 1 patients: management of side-effects

(2013) Angeli Chopra et al.   LIVER INTERNATIONAL

Drug–drug interactions during antiviral therapy for chronic hepatitis C

(2013) Jennifer J. Kiser et al.   Nature Reviews Gastroenterology & Hepatology

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

(2013) Eric Lawitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis C Virus Screening and Management of Seroconversions in Hemodialysis Facilities

(2013) Chukwuma Mbaeyi et al.   SEMINARS IN DIALYSIS

Hepatitis C virus infection in hemodialysis patients

(2013) Anais Vallet-Pichard et al.   Clinics and Research in Hepatology and Gastroenterology

Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function

(2012) Michelle Treitel et al.   CLINICAL PHARMACOKINETICS

Histological evolution of hepatitis C virus infection after renal transplantation

(2012) Silvia Naomi de Oliveira Uehara et al.   CLINICAL TRANSPLANTATION

The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience

(2012) Neeraj Singh et al.   CLINICAL TRANSPLANTATION

New Virologic Tools for Management of Chronic Hepatitis B and C

(2012) Stéphane Chevaliez et al.   GASTROENTEROLOGY

Incidence of hepatitis C virus infection in patients on hemodialysis: A systematic review and meta-analysis

(2012) Yingying Su et al.   Hemodialysis International

Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

(2012) Khayriyyah Mohd Hanafiah et al.   HEPATOLOGY

Is early virological response as predictive of the hepatitis C treatment response in dialysis patients as in non-uremic patients?

(2012) Patricia da Silva Fucuta Pereira et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: Is it feasible?

(2012) Jérôme Dumortier et al.   JOURNAL OF CLINICAL VIROLOGY

Transcription-mediated amplification (TMA) for the assessment of viremia in hemodialysis patients with hepatitis C

(2012) Dauana O. Bastos et al.   JOURNAL OF MEDICAL VIROLOGY

Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis

(2012) F. Fabrizi et al.   JOURNAL OF VIRAL HEPATITIS

Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?

(2012) F. Fabrizi et al.   JOURNAL OF VIRAL HEPATITIS

Kidney Transplantation Alone in ESRD Patients With Hepatitis C Cirrhosis

(2012) Stalin Campos et al.   TRANSPLANTATION

Kidney Transplantation Alone in ESRD Patients With Hepatitis C Cirrhosis

(2012) Anil S. Paramesh et al.   TRANSPLANTATION

Experience of Fibrosing Cholestatic Hepatitis With Hepatitis C Virus in Kidney Transplant Recipients

(2012) A.R. Siddiqui et al.   TRANSPLANTATION PROCEEDINGS

Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients

(2012) Abdulrahman A Aljumah   WORLD JOURNAL OF GASTROENTEROLOGY

Transient Elastography to Assess Hepatic Fibrosis in Hemodialysis Chronic Hepatitis C Patients

(2011) C.-H. Liu et al.   Clinical Journal of the American Society of Nephrology

Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?

(2011) Cristina Gluhovschi et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals

(2011) Patrice Cacoub et al.   JOURNAL OF HEPATOLOGY

Acute hepatitis C in Brazil: Results of a national survey

(2011) Adalgisa de Souza Paiva Ferreira et al.   JOURNAL OF MEDICAL VIROLOGY

Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C

(2011) Mark S. Sulkowski et al.   Nature Reviews Gastroenterology & Hepatology

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

(2011) Bruce R. Bacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Retreatment of HCV Infection

(2011) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome

(2010) Simone Lanini et al.   BMC INFECTIOUS DISEASES

Pegylated Interferon Alfa‐2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C

(2010) Chen‐Hua Liu et al.   CLINICAL INFECTIOUS DISEASES

Management of Acute Hepatitis C

(2010) Anurag Maheshwari et al.   Clinics in Liver Disease

Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience

(2010) Khalid Alsaran et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials

(2010) Fabrizio Fabrizi et al.   JOURNAL OF MEDICAL VIROLOGY

Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials

(2010) F. Fabrizi et al.   JOURNAL OF VIRAL HEPATITIS

The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C

(2010) Chen-Hua Liu et al.   KIDNEY INTERNATIONAL

Hepatic disorders in chronic kidney disease

(2010) Fabrizio Fabrizi et al.   Nature Reviews Nephrology

Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey

(2010) K. Saune et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis population

(2010) Vinaya Rao et al.   RENAL FAILURE

Unfractionated Heparin for Hemodialysis: Still the Best Option

(2010) Robert E. Cronin et al.   SEMINARS IN DIALYSIS

Adverse Impact of Hepatitis C Virus Infection on Renal Replacement Therapy and Renal Transplant Patients in Australia and New Zealand

(2010) David R. Scott et al.   TRANSPLANTATION

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

(2009)   AMERICAN JOURNAL OF TRANSPLANTATION

Interferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological Response

(2009) C. E. Gordon et al.   Clinical Journal of the American Society of Nephrology

Pegylated interferon  -2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy

(2009) C-H Liu et al.   GUT

Clinical and Laboratory Characteristics of Acute Hepatitis C in Patients With End-stage Renal Disease on Hemodialysis

(2009) Lara B. Lemos et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

HCV Response in Patients With End Stage Renal Disease Treated With Combination Pegylated Interferon α-2a and Ribavirin

(2009) Wyel Hakim et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis

(2009) Laurent Alric et al.   TRANSPLANT INTERNATIONAL

Pegylated interferon-α-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study

(2009) Georges-Philippe Pageaux et al.   TRANSPLANT INTERNATIONAL

Correlation Between Fibroscan, Liver Biopsy, and Clinical Liver Function in Patients With Hepatitis C Virus Infection After Renal Transplantation

(2009) R. Muñoz et al.   TRANSPLANTATION PROCEEDINGS

Interferon Treatment in Hemodialysis Patients With Chronic Hepatitis C Virus Infection: A Systematic Review of the Literature and Meta-analysis of Treatment Efficacy and Harms

(2008) Craig E. Gordon et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Impact of cyclosporine‐based immunosuppressive therapy on liver histology of hepatitis C virus–infected renal transplant patients

(2008) Leonardo L. Schiavon et al.   HEPATOLOGY

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials

(2008) F. Fabrizi et al.   JOURNAL OF VIRAL HEPATITIS

Foreword

(2008)   KIDNEY INTERNATIONAL

Hepatitis C among Predialysis Patients: Prevalence and Characteristics in a Large Cohort of Patients

(2008) Lara B. Lemos et al.   NEPHRON CLINICAL PRACTICE